AERIE PHARMACEUTICALS INC (AERI)

US00771V1089 - Common Stock

15.25  +0.01 (+0.07%)

After market: 15.25 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
69.89M
189.04%		83.14M
18.96%		194.134M
133.50%		140.26M
-27.75%
EBITDA
YoY % growth
-182.35M
12.04%		-149.32M
18.11%		-39.955M
73.24%		-76.355M
-91.10%
EBIT
YoY % growth
-187.49M
10.61%		-155.69M
16.96%		-46.354M
70.23%		-83.293M
-79.69%
Operating Margin
-268.26%-187.26%-23.88%-59.38%
EPS
YoY % growth
-3.40
26.41%		-3.10
8.82%		-1.02
67.10%		-1.89
-85.63%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.44
-140.25%
Revenue
Q2Q % growth		39.129M
-65.88%
EBITDA
Q2Q % growth		-16.472MN/AN/AN/AN/A
EBIT
Q2Q % growth		-18.121M
-135.02%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 -0.27
62.50%		-0.450.1839.47%
Q2 2022
Q2Q % growth		 -0.32
52.24%		-0.570.2544.16%
Q1 2022
Q2Q % growth		 -0.66
8.33%		-0.670.010.99%
Q4 2021
Q2Q % growth		 1.09
237.97%		-0.691.78258.61%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth		 36.129M
23.25%		36.195M-66K-0.18%
Q2 2022
Q2Q % growth		 33.311M
22.53%		33.106M205K0.62%
Q1 2022
Q2Q % growth		 29.835M
29.89%		30.466M-631K-2.07%
Q4 2021
Q2Q % growth		 114.666M
364.61%		32.083M82.583M257.40%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A